4/A

PRIMARY DOCUMENT

Company: UNITED THERAPEUTICS Corp
Filed: March 16, 2021
Period of Report: March 15, 2018
Accession Number: 0001127602-21-010884

View Document ↗ View on SEC.gov ↗